AspenBio Pharma, Inc. Stock Nasdaq
Equities
US0453462022
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 16 | Top Cryptocurrencies Mixed; Bitcoin Falls to $65,000 | MT |
May. 15 | Top Cryptocurrencies Rise; Surging Bitcoin Tops $66,000 | MT |
Financials (USD)
Sales 2024 * | 422M | Sales 2025 * | 870M | Capitalization | 2.89B |
---|---|---|---|---|---|
Net income 2024 * | 165M | Net income 2025 * | 153M | EV / Sales 2024 * | 3.28 x |
Net cash position 2024 * | 1.51B | Net cash position 2025 * | 2.1B | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
41.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.78% |
Latest transcript on AspenBio Pharma, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Jason Les
CEO | Chief Executive Officer | 38 | 17-11-02 |
Colin Yee
DFI | Director of Finance/CFO | 48 | 22-03-31 |
David Schatz
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hubert Marleau
BRD | Director/Board Member | 80 | 20-11-16 |
Lance D'Ambrosio
BRD | Director/Board Member | 66 | 21-05-23 |
Benjamin Yi
CHM | Chairman | 42 | 18-10-21 |
1st Jan change | Capi. | |
---|---|---|
+49.32% | 3.9B | |
-8.04% | 3.43B | |
-1.45% | 1.29B | |
-33.06% | 790M | |
-15.62% | 706M | |
-36.88% | 701M | |
-40.57% | 672M | |
-68.19% | 562M | |
-45.70% | 467M |